Hailed as the “wonder drug” for weight loss, the diabetes drug Ozempic, also known as Semaglutide, has gained fame on social media and among Hollywood stars. Elon Musk has also praised it. But what Semaglutide actually does to your body is devastating, not just dangerous.
Originally marketed as a drug for the treatment of type 2 diabetes and long-term weight management, Semaglutide gained traction in the medical community for its ability to lower blood sugar or control glycosylated hemoglobin levels.
Let us break it down for you:
In fact, GLP-1 has revolutionized the management of type 2 diabetes,
BUT The same hormone has also been shown to slow the passage of food from the stomach to the small intestine.
What does this mean: So with GLP-1, you feel full faster. Too much faster.
- A randomized controlled trial found that a once-weekly injection of 2.4 mg of the drug Resulted in a mean change of −14.9% in body weight at 68 weeks compared to −2.4% for placebo.
“When you change your body’s insulin reaction, you crave a different food. That’s what’s happening.
– Isabelle Kenyon, founder and CEO of Calibrate, a telehealth weight loss startup advocating for Semaglutide, in an interview with The Guardian
In simple words: It’s almost like you’re hacking into your body’s hormonal mainframe and tinkering with food hormones until certain food cravings basically go away.
GLP-1 treatment manifests itself at the physiological level, rather than at the mechanical level. And so doctors are increasingly prescribing the drug off-label simply for its effect in helping people lose weight.
Semaglutide is sold under the brand names Wegovy and Ozempic, among others.
- The injectable version (Ozempic) was approved solely as an antidiabetic in the United States in 2017.
- In 2021, the US Food and Drug Administration (FDA) approved semaglutide injection sold under the brand name Wegovy for long-term weight management in adults.
- In 2020, it was the 129th most prescribed drug in the United States, with nearly 5 million active prescriptions.
Side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. In people with heart problems, it can cause damage to the retina of the eye (retinopathy).
Less common side effects include hair loss, heartburn, and swelling at the injection site. Some studies have even linked semaglutide to an increased risk of thyroid cancer, as well as pancreatitis and gallstones.
But among the long list of minor and serious side effects, the one most often taken for granted is the one that gives the drug its legitimacy: His uncanny ability to destroy appetites completely. What it means is that you just don’t feel like eating. Or, if you see junk food, you feel like throwing up.
online communities across the internet are filled with stories of how the drug has made food downright disgusting and, in some extreme cases, even incites an outright hatred for food.
However, on the same Internet forums, proponents of the drug would argue that such risks are acceptable, given the wide range of dangers associated with obesity: heart disease, stroke, sleep apnea, cancer, osteoarthritis, and of course. , type 2 diabetes. .
Enter Musk: Twitter’s new big boss, Elon Musk, has proven to be a (not) surprisingly drug-addict:
The Neuralink co-founder seemed to suggest that Semaglutide would be a suitable alternative for the time being, stating that his Neuralink neural implant technology could soon address the problem of morbid obesity as well, with experts back up their claims.
For those who use the drug, it is probably a choice between the devil and the depths of the sea. Whether due to medical compulsion or the increasingly prevalent cultural stigmas surrounding the aesthetics of obesity (rather than the actual health risks it poses), it seems that the prospects for weight loss completely overshadow the potential threats to obesity. your well-being (as well as the joy of biting into a hamburger).